Airain Ltd’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$567K Buy
+6,886
New +$562K 0.03% 512
2016
Q2
Sell
-133,419
Closed -$9.61M 781
2016
Q1
$9.61M Buy
133,419
+112,455
+536% +$8.51M 0.66% 33
2015
Q4
$1.77M Buy
+20,964
New +$1.74M 0.12% 210
2014
Q1
Sell
-124,553
Closed -$6.35M 789
2013
Q4
$6.35M Buy
124,553
+103,181
+483% +$5.17M 0.82% 18
2013
Q3
$1.08M Sell
21,372
-1,024
-5% -$53.6K 0.2% 126
2013
Q2
$1.1M Buy
+22,396
New +$1.22M 0.16% 153

Other funds holding LLY

Airain Ltd's LLY Position: Q2 2017 in Review

Airain Ltd opened a new position in Eli Lilly (LLY) in Q2 2017: 6,886 shares worth $567K. The stake represents 0.03% of the portfolio and ranks #512 among its holdings. This is a return to the name: Airain Ltd previously reported a position in LLY as recently as Q1 2016.

Airain Ltd first reported a position in LLY in Q2 2013 and has held it in 6 quarters since. The position peaked at $9.61M in Q1 2016. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Airain Ltd held 6,886 shares of Eli Lilly worth $567K as of Q2 2017.
  • Eli Lilly was a new Airain Ltd position in Q2 2017.
  • Eli Lilly made up 0.03% of Airain Ltd's portfolio in Q2 2017, its #512 holding.
  • Airain Ltd first reported a position in Eli Lilly in Q2 2013 and has held it in 6 quarters since.
  • Airain Ltd's Eli Lilly position peaked at $9.61M in Q1 2016.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.